Literature DB >> 22539099

[Interventional left atrial appendage occlusion. A reasonable alternative to oral anticoagulation - even in the era of the new substances?].

B Plicht1, P Kahlert, R Erbel, T F M Konorza.   

Abstract

As a potential alternative to long-term oral anticoagulation with vitamin K antagonists in patients with atrial fibrillation, the interventional left atrial appendage occlusion has shown to be non-inferior regarding neurological events. With the new oral direct factor II and factor Xa inhibitors playing an emerging role in stroke prophylaxis, an individual treatment strategy has to be found weighing bleeding and stroke risk against the peri-interventional complication rate based on established risk scores.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22539099     DOI: 10.1007/s00059-012-3621-1

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  15 in total

1.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Authors:  Ron Pisters; Deirdre A Lane; Robby Nieuwlaat; Cees B de Vos; Harry J G M Crijns; Gregory Y H Lip
Journal:  Chest       Date:  2010-03-18       Impact factor: 9.410

2.  Adequacy of anticoagulation in patients with atrial fibrillation coming to a hospital.

Authors:  T J Bungard; M L Ackman; G Ho; R T Tsuyuki
Journal:  Pharmacotherapy       Date:  2000-09       Impact factor: 4.705

3.  Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.

Authors:  Stefan H Ostermayer; Mark Reisman; Paul H Kramer; Ray V Matthews; William A Gray; Peter C Block; Heyder Omran; Antonio L Bartorelli; Paolo Della Bella; Carlo Di Mario; Carlo Pappone; Paul N Casale; Jeffrey W Moses; Athena Poppas; David O Williams; Bernhard Meier; Allan Skanes; Paul S Teirstein; Michael D Lesh; Toshiko Nakai; Yves Bayard; Kai Billinger; Thomas Trepels; Ulrike Krumsdorf; Horst Sievert
Journal:  J Am Coll Cardiol       Date:  2005-07-05       Impact factor: 24.094

4.  Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke.

Authors:  Jeff S Healey; Eugene Crystal; Andre Lamy; Kevin Teoh; Lloyd Semelhago; Stefan H Hohnloser; Irene Cybulsky; Labib Abouzahr; Corey Sawchuck; Sandra Carroll; Carlos Morillo; Peter Kleine; Victor Chu; Eva Lonn; Stuart J Connolly
Journal:  Am Heart J       Date:  2005-08       Impact factor: 4.749

5.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Authors:  A John Camm; Paulus Kirchhof; Gregory Y H Lip; Ulrich Schotten; Irene Savelieva; Sabine Ernst; Isabelle C Van Gelder; Nawwar Al-Attar; Gerhard Hindricks; Bernard Prendergast; Hein Heidbuchel; Ottavio Alfieri; Annalisa Angelini; Dan Atar; Paolo Colonna; Raffaele De Caterina; Johan De Sutter; Andreas Goette; Bulent Gorenek; Magnus Heldal; Stefan H Hohloser; Philippe Kolh; Jean-Yves Le Heuzey; Piotr Ponikowski; Frans H Rutten
Journal:  Eur Heart J       Date:  2010-08-29       Impact factor: 29.983

6.  Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience.

Authors:  Jai-Wun Park; Armando Bethencourt; Horst Sievert; Gennaro Santoro; Bernhard Meier; Kevin Walsh; Jose Ramon Lopez-Minguez; Jose Ramon Lopez-Minquez; David Meerkin; Mariano Valdés; Oliver Ormerod; Boris Leithäuser
Journal:  Catheter Cardiovasc Interv       Date:  2011-03-08       Impact factor: 2.692

7.  Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Authors:  Vivek Y Reddy; David Holmes; Shephal K Doshi; Petr Neuzil; Saibal Kar
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

8.  Thrombus formation after left atrial appendage exclusion using an Amplatzer cardiac plug device.

Authors:  Ignacio Cruz-Gonzalez; Javier Martín Moreiras; Eulogio García
Journal:  Catheter Cardiovasc Interv       Date:  2011-11-15       Impact factor: 2.692

9.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

10.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Authors:  David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Christopher M Mullin; Peter Sick
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.